NEW YORK (360Dx) – ClearLight Diagnostics said today that it has completed a $2.77 million financing round.
Participants in the financing round included CS Investors, Pivotal Paramount Investment, and Stanford University. The financing will be used to continue development of ClearLight's platform, it said.
The ClearLight technology allows for the creation of transparent tissue-gel composites, producing fully assembled, intact tissue, which is permeable to macromolecules and optically transparent. This, in turn, allows for robust three-dimensional imaging of subcellular components and heterogeneous cellular interactions within the tumor microenvironment. When paired with a microscopy method called clarity optimized light-sheet microscopy, the technology gives researchers an in-depth view of key biomarkers from lipid-cleared samples.
The Sunnyvale, California-based company previously raised $3.5 million in late 2016.